Constantine Tanywe Asahngwa

Constantine Tanywe Asahngwa

Auto-generated profile, based on publicly available information

Constantine Tanywe Asahngwa

Department of Anthropology, The University of Yaounde 1, Yaounde, Cameroon

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
JZJude Tsafack Zefack
Jude Tsafack Zefack
CAChabeja Achangwa
Chabeja Achangwa
RTRick Tchamani
Rick Tchamani
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
Background: Mpox, a zoonotic disease endemic to Africa, presents a significant public health threat with variable severity driven by viral clades and host factors. After over 50 years of outbreaks, this study aimed at providing a comprehensive continent-wide assessment of its severity and mortality for evidence-based public health planning and clinical management. Methods: This systematic review and meta-analysis, conducted per PRISMA guidelines and registered with PROSPERO (CRD420251133745), aggregated data from studies on mpox severity and mortality in Africa from 1970 to 2025. A systematic search of multiple databases was performed. The primary outcomes were the mpox severity rate (proportion of severe cases among confirmed cases) and the case fatality rate (CFR). Random-effects models were used due to high heterogeneity. Results: The analysis included 37 records on severity and 43 on mortality among confirmed cases. The pooled severity rate among confirmed mpox cases in Africa was 43.77% (95% CI: 36.27–51.58). The pooled CFR was 3.92% (95% CI: 1.88–7.60) for confirmed cases and 2.49% (95% CI: 1.32–4.62) for suspected cases. A significant temporal decline was observed; after the 2022 global outbreak, the CFR for confirmed cases dropped to 1.04% from 6.50% beforehand. Substantial geographical disparities existed, with the Central African region bearing the highest burden (severity: 45.51%; CFR: 5.44%), compared to West Africa (severity: 25.43%; CFR: 0.97%). Infections with Clades Ia and Ib were associated with higher severity, whereas Clade II was linked to milder disease. Key risk factors for severe outcomes and death included young age (<10 years), HIV coinfection, lack of prior smallpox vaccination, and pregnancy. Community-based studies reported higher CFRs than hospital-based studies. No significant publication bias was detected, and sensitivity analyses confirmed the robustness of the pooled estimates. Conclusion: This study confirms a high but declining burden of severe and fatal mpox in Africa, characterized by significant temporal, geographic, and clade-specific variations. While a global shift towards milder disease is evident, Central Africa remains disproportionately at risk due to the persistent circulation of more virulent clades and underlying health inequities. Sustained investment in surveillance, vaccination, and strengthened healthcare capacity in endemic regions is crucial to reduce future morbidity and mortality.

8 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
AZArmel Zemsi
Armel Zemsi
JNJonathan Hangi Ndungo
Jonathan Hangi Ndungo
CAChabeja Achangwa
Chabeja Achangwa
DTDavy Roméo Takpando-Le-Grand
Davy Roméo Takpando-Le-Grand
SNSaralees Nadarajah
Saralees Nadarajah
Background: Mpox, caused by the Mpox virus, is a zoonotic disease historically endemic in Central and West Africa. The Democratic Republic of Congo (DRC) bears the highest burden, with evolving epidemiology and significant public health challenges. Understanding severity and mortality trends is critical for global control efforts. Methods: This systematic review and meta-analysis followed PRISMA guidelines to synthesize evidence on Mpox severity and mortality in the DRC from 1970 to 2024. We searched PubMed, ScienceDirect, Scopus, Web of Science identifying 19 eligible studies after screening 5443 records. Data on severity and death among suspected and confirmed cases were extracted. Random-effects models addressed high heterogeneity, and subgroup analyses examined temporal trends, regional differences, and healthcare settings. Meta-regression explored sources of heterogeneity, adjusting for study year, region, and setting. Results: We included a total of 19 study reports. The pooled severity rate among 3,280 confirmed cases was 39.47% (95% confidence interval [CI]: 29.11-50.86), declining from 46.34% (95% CI: 37.07-55.87) pre-2022 to 25.83% (95% CI: 11.16-49.11) in 2022-2024. Northern (43.82%; 95% CI: 37.81-50.03) and Central (63.89%; 95% CI: 57.10-70.30) regions had higher severity than Eastern regions (26.04%; 95% CI: 8.77-56.31). Case fatality rates (CFRs) were 1.70% (95% CI: 0.72-3.95) for suspected cases and 2.46% (95% CI: 0.65-8.85) for confirmed cases, with Western DRC disproportionately affected (22.03%; 95% CI: 13.25-34.34). Community settings showed higher CFRs (3.69%; 95% CI: 0.78-15.81) than hospitals (0.77%; 95% CI: 0.32-1.84), underscoring healthcare access disparities. Meta-regression confirmed study year (p = 0.044) as significant predictors of outcomes case severity heterogeneity and study year ( p = 0.016), region ( p = 0.003) and setting ( p = 0.041), with mortality declining over time but remaining elevated in resource-limited areas. Conclusion: Mpox continues to impose a substantial burden in the DRC, with high severity and mortality rates, particularly in Western/Central regions and community settings. The observed temporal decline in severity and CFRs suggests the impact of strengthened surveillance and healthcare capacity. However, regional disparities persist might be due to inequitable healthcare access and potential differences in viral clades. Targeted interventions, including vaccination in high-risk areas, community education, and healthcare system strengthening are urgently needed.

23 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
SDSolange Dabou
Solange Dabou
BABrian Ngongheh Ajong
Brian Ngongheh Ajong
GNGuy Stéphane Nloga
Guy Stéphane Nloga
TITakougang Innocent
Takougang Innocent
Background Emergency medicine systems are vital for reducing mortality and disability, yet Cameroon faces significant healthcare access challenges, with only 0.6% of GDP allocated to public health and 70% of health expenditures paid out-of-pocket. This study assessed proportion of population benefiting from health coverage, patterns, and associated factors in Cameroon to inform policies aimed at achieving universal health coverage (UHC). Methods A nationally representative cross-sectional survey was conducted from February to March 2024, involving 1,200 adults selected via multistage random sampling. Data were collected through face-to-face interviews by national Afrobarometer team, and analyzed with R Statistics version 4.4.2. Logistic regression identified factors associated with medical coverage, adjusting for sociodemographic, economic, and occupational variables. Results A proportion of 7.9% (95% CI: 6.4–9.6) of respondents reported benefiting from a health coverage in 2024, with the lowest rates reported in the North, Adamawa, Centre, and North-West regions. Private health insurance was the most common (44.3%), followed by civil servant schemes (20.5%) and community-based insurance (15.9%). Unemployed individuals were twice as likely to lack coverage (aOR = 2.22, 95% CI: 1.42–3.51). Those with secondary education had twice the odds of being uninsured compared to tertiary-educated individuals (aOR = 2.00, 95% CI: 1.21–3.27). Insured individuals were more likely to use healthcare services (9.6%; p = 0.028), reported easier access to medical care (15.8%; p = 0.010), and expressed fewer concerns about healthcare access (23.4%; p < 0.001). Barriers among the uninsured included high costs (37.1%), lack of information (31.6%), complex registration processes (8.5%) and geographical constraints. Most of the community members reported being quite (51.1%) or very satisfied (23.9%) by the medical coverage they are benefiting from. Notably, 68% of respondents supported higher taxes to improve healthcare access. Conclusion Cameroon’s suboptimal medical coverage reflects systemic inequities tied to employment and education. Expanding employer-independent schemes, subsidizing premiums, and leveraging community-based models are critical to advancing UHC. Public willingness to contribute through taxes suggests political viability for systemic reforms.

30 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
RTRick Tchamani
Rick Tchamani
CAChabeja Achangwa
Chabeja Achangwa
ANAriane Nouko
Ariane Nouko
JDJessica Davies
Jessica Davies
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
Background: Mpox, a zoonotic disease long endemic in Africa, has gained renewed global attention due to recent outbreaks. Effective control of the virus relies on public adherence to preventive measures, which is largely influenced by the population’s knowledge and perception. This systematic review and meta-analysis aimed to determine the pooled prevalence of good knowledge and positive perception toward mpox in Africa and to identify associated factors. Methods: Following PRISMA guidelines, a comprehensive search was conducted across multiple relevant databases and grey literature sources. Studies conducted in African countries that assessed knowledge and/or perception of mpox were included. Pooled prevalences with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and meta-regression were performed to explore heterogeneity. Results: The analysis incorporated 38 studies with 23,648 participants from 15 African countries. The pooled prevalence of good mpox knowledge was 43.12% (95% CI: 34.38–52.32), indicating significant gaps in awareness. Knowledge levels varied substantially across subgroups. By participant type, teachers exhibited the highest knowledge (89.43%), followed by medical students (56.02%) and healthcare workers (51.39%), while the general population demonstrated markedly lower knowledge (14.88%). Geographically, Southern Africa had the highest knowledge prevalence (77.92%), whereas Central Africa had the lowest (19.20%). At the country level, South Africa (77.92%) and Kenya (68.31%) recorded the highest levels, while Libya (5.34%) and Somalia (9.68%) had the lowest. The pooled prevalence of a positive perception or attitude toward mpox was 54.22% (95% CI: 44.94–63.21). Pregnant women (81.43%) and healthcare workers (60.32%) reported the most positive perceptions, whereas community health workers showed the least (10.19%). Positive perception was highest in Northern Africa (63.02%) and lowest in Central Africa (7.27%). Individual levels of mpox knowledge and perception were significantly associated with several sociodemographic and non-sociodemographic factors. Conclusions: This study reveals that overall knowledge of mpox across Africa is insufficient, and positive perception is only moderate, with considerable disparities across different populations and regions. The findings underscore an urgent need for targeted educational campaigns, enhanced training for healthcare workers, and context-specific communication strategies to boost awareness, improve attitudes, and strengthen continent-wide outbreak control and preparedness.

28 May 2026 in BMC Public Health
Verified
Journal Article
Open access
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
RTRick Tchamani
Rick Tchamani
CAChabeja Achangwa
Chabeja Achangwa
ANAriane Nouko
Ariane Nouko
JDJessica Davies
Jessica Davies
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
Mpox, a zoonotic disease long endemic in Africa, has gained renewed global attention due to recent outbreaks. Effective control of the virus relies on public adherence to preventive measures, which is largely shaped by the population's knowledge and perceptions. This systematic review and meta-analysis aimed to determine the pooled prevalence of good knowledge and positive perceptions of mpox in Africa and to identify associated factors. Following PRISMA 2020 guidelines, a comprehensive search was conducted in PubMed, Web of Science, Scopus Embase, CINAHL, ScienceDirect, African Journals Online. Studies conducted in African countries that assessed knowledge and/or perception of mpox were included. Pooled prevalence with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup analyses and meta-regression were performed to explore heterogeneity. The analysis included 38 studies with 23,648 participants from 15 African countries. The pooled prevalence of good mpox knowledge was 43.12% (95% CI: 34.38-52.32), indicating significant gaps in awareness. Knowledge varied substantially across subgroups. By participant type, teachers had the highest knowledge prevalence (89.43%), followed by healthcare workers (50.54%), while the general population had markedly lower knowledge (14.88%). Regionally, Southern Africa had the highest knowledge prevalence (77.92%), whereas Central Africa had the lowest (19.20%). At the country level, South Africa (77.92%) and Kenya (68.31%) recorded the highest levels, while Libya (5.34%) and Somalia (9.68%) had the lowest. The pooled prevalence of a positive perception or attitude toward mpox was 54.22% (95% CI: 44.94-63.21). Pregnant women (81.43%) and healthcare workers (57.37%) reported the most positive perceptions, whereas community health workers showed the least (10.19%). Positive perception was highest in Northern Africa (63.02%) and lowest in Central Africa (7.27%). Individual levels of mpox knowledge and perception were associated with age, gender, education and profession. This study reveals that overall knowledge of mpox across Africa is insufficient, and that positive perceptions are only moderate, with considerable disparities across different populations and regions. The findings underscore an urgent need for targeted educational campaigns, enhanced training for healthcare workers, and context-specific communication strategies to boost awareness, improve attitudes, and strengthen continent-wide outbreak control and preparedness.

6 May 2026 in Journal of Public Health and Preventive Medicine
Verified
Journal Article
Open access
Cheuyem Lekeumo Fabrice ZobelCheuyem Lekeumo Fabrice Zobel
Cheuyem Lekeumo Fabrice Zobel
ATArole Darwin Touko
Arole Darwin Touko
CAChabeja Achangwa
Chabeja Achangwa
RTRick Tchamani
Rick Tchamani
EAEno Ethel Ambo
Eno Ethel Ambo
CAConstantine Tanywe Asahngwa
Constantine Tanywe Asahngwa
Background: Human papillomavirus (HPV) infection is a major public health concern in Cameroon, where cervical cancer remains the second leading cause of cancer-related morbidity and mortality among women. Despite the availability of effective preventive measures, their uptake remains suboptimal and is influenced by population-level knowledge and awareness. This study aimed to synthesize existing evidence on HPV-related knowledge and its associated factors in Cameroon. Methods: This review included studies assessing knowledge of HPV as a sexually transmitted infection (STI), its causal role in cervical cancer, and overall good HPV knowledge. A comprehensive and systematic search was conducted across PubMed, Scopus, Web of Science, Embase, the Cochrane Library, and local online databases. Study quality was appraised using the Joanna Briggs Institute critical appraisal tool. Pooled prevalence estimates were calculated using random-effects models (DerSimonian and Laird). Heterogeneity was assessed using the I² statistic and explored through subgroup analyses. Results: A total of 32 studies involving 13, 457 participants were included. The pooled prevalence of overall good HPV knowledge was 27.4% (95% CI: 7.6–63.2; 7 studies; n = 3,312), with considerable heterogeneity (I² = 99.3%). Knowledge of HPV as a cause of cervical cancer was 27.9% (95% CI: 15.8–44.4; 26 studies; n = 8,688), while knowledge of HPV as an STI was 47.1% (95% CI: 31.4–63.5; 18 studies; n = 9,040). Healthcare workers demonstrated the highest levels of knowledge (80.2% for HPV as an STI; 78.7% for HPV as a cause of cervical cancer), whereas students (43.4% and 10.2%, respectively) and women from the general population (30.6% and 19.9%, respectively) showed substantially lower levels. Factors associated with poor knowledge included Christian affiliation (OR = 1.46; 95% CI: 0.08–26.06) and secondary level education (OR = 1.32; 95% CI: 0.66–2.63), although these associations were non-significant. Conclusions: This study reveals that, HPV-related knowledge in Cameroon remains low, particularly regarding the causal link between HPV and cervical cancer. These findings highlight the urgent need for targeted, context-specific educational interventions and strengthened public health strategies to improve awareness and uptake of HPV prevention measures.